Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Higashi Kuwata, Nobuyo ^a   Jinnin, Masatoshi ^a   Makino, Takamitsu ^a   Fukushima, Satoshi ^a   Inoue, Yuji ^a   Muchemwa, Faith C ^a   Yonemura, Yuji ^a   Komohara, Yoshihiro ^a   Takeya, Motohiro ^a   Mitsuya, Hiroaki ^a,b   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; MONOCLONAL ANTIBODY; STEROID; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MSR1 PROTEIN, HUMAN; SCAVENGER RECEPTOR A;

ADULT; ANTIGEN EXPRESSION; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SCORING SYSTEM; SKIN; SKIN BIOPSY; SYSTEMIC SCLEROSIS; AGED; BIOPSY; CELL LINEAGE; IMMUNOLOGY; LIMITED SCLERODERMA; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; BIOPSY; CELL LINEAGE; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CELL SURFACE; SCAVENGER RECEPTORS, CLASS A; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 78651412553     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3066     Document Type: Article

References (32)

1. Tuffanelli DL, Winkelmann RK. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol 1961, 84:359-371.
2. Ihn H. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix. Curr Rheumatol Rep 2005, 7:156-162. 10.1007/s11926-005-0069-9, 15760596.
3. Ihn H. Autocrine TGF-ß signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008, 49:103-113. 10.1016/j.jdermsci.2007.05.014, 17628443.
4. Ihn H, Sato S, Fujimoto M, Takehara K, Tamaki K. Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. Br J Rheumatol 1998, 37:1188-1192. 10.1093/rheumatology/37.11.1188, 9851267.
5. Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K. Characterization of autoantibodies to endothelial cells in systemic sclerosis: association with pulmonary fibrosis. Clin Exp Immunol 2000, 119:203-209. 10.1046/j.1365-2249.2000.01115.x, 1905540, 10606984.
6. Xie Y, Zhang X, Inoue Y, Wakasugi S, Makino T, Ihn H. Expression of CD1a and CD86 on scleroderma Langerhans cells. Eur J Dermatol 2007, 18:50-54.
7. Ishikawa O, Ishikawa H. Macrophage infiltration in the skin of patients with systemic sclerosis. J Rheumatol 1992, 19:1202-1206.
8. Varga J, Korn JH. Pathogenesis: emphasis on human data. Systemic sclerosis 2004, 63-97. Philadelphia, PA: Lippincott Williams & Wilkins, Clements PJ, Furst DE.
9. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007, 82:710-720. 10.1189/jlb.0307194, 17595377.
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35. 10.1038/nri978, 12511873.
11. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212. 10.1189/jlb.0602325, 12554797.
12. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686. 10.1016/j.it.2004.09.015, 15530839.
13. Raes G, Beschin A, Ghassabeh GH, De Baetselier P. Alternatively activated macrophages in protozoan infections. Curr Opin Immunol 2007, 19:454-459. 10.1016/j.coi.2007.05.007, 17628461.
14. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-11.
15. Kodelja V, Müller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997, 197:478-493.
16. Sulahian TH, Högger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000, 12:1312-1321. 10.1006/cyto.2000.0720, 10975989.
17. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001, 27:140-146. 10.1016/S0923-1811(01)00128-1, 11532378.
18. Riccieri V, Rinaldi T, Spadaro A, Scrivor R, Ceccarelli F, Franco MD. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol 2003, 22:102-106. 10.1007/s10067-002-0684-z, 12740673.
19. Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004, 138:540-546. 10.1111/j.1365-2249.2004.02642.x, 1809238, 15544634.
20. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type 1 interferons and toll-like receptor agonists. Arthritis Rheum 2007, 56:1010-1020. 10.1002/art.22382, 17328080.
21. Andrews BS, Friou GJ, Berman MA, Sandborg CI, Mirick G, Cesario TC. Changes in circulating monocytes in patients with progressive systemic sclerosis. J Rheumatol 1987, 14:930-935.
22. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-206.
23. Tomokiyo R, Jinnouchi K, Honda M, Wada Y, Hanada N, Hiraoka T, Suzuki H, Kodama T, Takahashi K, Takeya M. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 2002, 161:123-132. 10.1016/S0021-9150(01)00624-4, 11882324.
24. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K. Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 1991, 139:1411-1423. 1886471, 1750511.
25. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555. 10.1016/S1471-4906(02)02302-5, 12401408.
26. Higashi-Kuwata N, Makino T, Inoue Y, Takeya M, Ihn H. Alternatively activated macrophages (M2 macrophages) in the skin of patients with localized scleroderma. Exp Dermatol 2009, 18:727-729. 10.1111/j.1600-0625.2008.00828.x, 19320738.
27. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461. 10.2741/2692, 17981560.
28. Moonen JR, de Leeuw K, van Seijen XJ, Kallenberg CG, van Luyn MJ, Biji M, Harmsen MC. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007, 9:R84. 10.1186/ar2283, 2206388, 17764548.
29. Fertl A, Menzel M, Hofer TP, Morresi-Hauf A, Ziegler-Heitbrock L, Frankenberger M. Monitoring of glucocorticoid therapy by assessment of CD14+CD16+ monocytes: a case report. Immunobiology 2008, 213:909-916. 10.1016/j.imbio.2008.07.018, 18926305.
30. Sandanger T, Ryan L, Bohnhorst J, Inversen AC, Husebye H, Halaas T, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T. IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients. J Immunol 2009, 182:588-595.
31. Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S, Mack M, Roth J, Sunderkoetter C. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leuko Biol 2008, 84:644-650. 10.1189/jlb.1107768, 18611985.
32. Nakayama M, Kudoh T, Kaikita K, Yoshimura M, Oshima S, Miyamoto Y, Takeya M, Ogawa H. Class A macrophage scavenger receptor gene expression levels in peripheral blood mononuclear cells specifically increase in patients with acute coronary syndrome. Atherosclerosis 2008, 198:426-433. 10.1016/j.atherosclerosis.2007.09.006, 17945237.